Cannapharmarx (CPMD) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
CannapharmaRx, an emerging leader in cannabis production, has announced the shipment of its first order following approval for sales in multiple countries, with products sent to a Canadian LP and an upcoming order from Israel. The company is set to regularly distribute additional products every 2-3 weeks and expects to fulfill ongoing supply demands. CEO Dean Medwid expressed enthusiasm for the expansion of their global footprint and the establishment of long-term supply partnerships.
For further insights into CPMD stock, check out TipRanks’ Stock Analysis page.
